Table 3.
Diabetic Microvascular Complications at the Time of Registration in the Thai Type 1 Diabetes and Diabetes diagnosed Age before 30 years Registry, Care and Network (T1DDAR CN) Compared Between Young-Onset Type 1 Diabetes Mellitus (T1DM) and Type 2 Diabetes Mellitus (T2DM) Patients
| Diabetes complication | T1DM (n=301) | T2DM (n=95) | p-value |
|---|---|---|---|
| Diabetic retinopathy screening rate, n (%) | 245 (81.4) | 89 (93.7) | 0.004* |
| Mild to mod DR, n (%) | 17 (6.9) | 4 (4.5) | 0.428 |
| Severe NPDR/ PDR, n (%) | 9 (3.7) | 4 (4.5) | 0.717 |
| Vitreous hemorrhage/ macular edema, n (%) | 2 (0.8) | – | |
| DM duration to DR, years | 19.1 (13.9,24.6) | 16.0 (13.1,19.6) | 0.270 |
| Latest HbA1c, % | 7.9±1.1 | 8.9±2.1 | 0.266 |
| Diabetic nephropathy screening rate, n (%) | 247 (82.1) | 83 (87.4) | 0.226 |
| Microalbuminuria, n (%) | 25 (10.1) | 33 (40.2) | < 0.001* |
| DM duration to microalbuminuria, years | 13.8 (9.2,20.7) | 5.7 (4.0,9.4) | < 0.001* |
| Latest HbA1c, % | 8.8±2.3 | 8.6±1.9 | 0.689 |
| Diabetic neuropathy, n (%) | 119 (39.5) | 55 (57.9) | 0.002* |
| Diabetes neuropathy, n (%) | 4 (3.4) | 3 (5.5) | 0.514 |
| Latest HbA1c, % | 9.4±3.8 | 8.2±0.5 | 0.614 |
Note: Data were presented as mean ± SD and median (IQR) as appropriate. *Significant at p-value < 0.05.